Who owns INVIVO THERAPEUTICS HLDGS CO?
- Ticker: NVIVQ
- CUSIP Number: 46186m605
Tip: Access positions for across all investors
Analyze quarterly positions in Invivo Therapeutics Hldgs with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Invivo Therapeutics Hldgs stock
Who bought or sold INVIVO THERAPEUTICS HLDGS CO this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 31k | $23k | 8% | Dec 2023 |
|
| Wells Fargo & Company | 24.00 | $18.000000 | 4% | Dec 2023 |
|
| Advisor Group Holdings | 5.00 | $3.000000 | -17% | Dec 2023 |
|
| Vima | 2.00 | $1.000000 | 100% | Dec 2023 |
|
| Sugarloaf Wealth Management | 1.00 | $0 | 0% | Mar 2024 |
|
| UBS Group | 1.00 | $1.000000 | -99% | Dec 2023 |
|
Who sold out of Invivo Therapeutics Hldgs?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Indiana Trust & Investment Management | Dec 2023 | 2.00 | $1.000000 |
| Hanson McClain Advisors | Dec 2023 | 1.00 | $1.000000 |
| Milestone Investment Advisors | Sep 2023 | 1.00 | $2.000000 |